Palvella Therapeutics PVLA
NASDAQ PVLA
$163.94 -4.77 (-2.83%)
At close: Nov 11, 2026 · 4:00 PM EST

Palvella Therapeutics (PVLA) Asset Writedowns and Impairment (2023)

Updated

Palvella Therapeutics (PVLA) posted Asset Writedowns and Impairment of -$981,000 for Q4 2023.

Analysis

Palvella Therapeutics (PVLA) Asset Writedowns and Impairment (2023) Analysis & Trends

For FY2023, Palvella Therapeutics' Asset Writedowns and Impairment came in at $13.91 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Palvella Therapeutics 2.47 Bn 2.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -981,000.00
Sep 30, 2023 14.89 Mn
API Access

Palvella Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=PVLA&period=max&api_key=YOUR_API_KEY